by | Nov 29, 2016 | 2016 News
Genalyte recently presented promising data on its new Maverick Detection System, demonstrating its potential to be used in a near patient setting to improve turnaround time for test results and diagnosis for several conditions, including rheumatoid arthritis (RA)....
by | Nov 21, 2016 | 2016 News
Theranos competitor Genalyte just announced it has raised an equity round of $36 million in funding led by Khosla Ventures and Redmile Group. The San Diego-based startup leverages lab-on-a-chip technology it says can run through up to 128 different tests on a single...
by | Nov 21, 2016 | 2016 News
The potential remains. From one drop of blood, medical professionals could run dozens of tests and glean results in a matter of minutes. San Diego-based Genalyte was making this a reality long before Theranos burst onto the scene. And with $36 million in new funding —...
Recent Comments